发明授权
- 专利标题： UREA COMPOUNDS AND METHODS OF USES
- 专利标题（中）： 脲衍生物及其用途
-
申请号： EP01964009.3申请日： 2001-08-15
-
公开(公告)号： EP1309589B1公开(公告)日： 2006-03-15
- 发明人: SANTORA, Vincent , ASKEW, Benny , GHOSE, Arup , HAGUE, Andrew , KIM, Tae, Seong , LABER, Ellen , LI, Aiwen , LIAN, Brian , LIU, Gang , NORMAN, Mark, Henry , SMITH, Leon , TASKER, Andrew , TEGLEY, Christopher , YANG, Kevin
- 申请人： AMGEN INC.
- 申请人地址： One Amgen Center Drive Thousand Oaks, CA 91320-1799 US
- 专利权人： AMGEN INC.
- 当前专利权人： AMGEN INC.
- 当前专利权人地址： One Amgen Center Drive Thousand Oaks, CA 91320-1799 US
- 代理机构： Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
- 优先权： US225793P 20000815; US930753P 20010814
- 国际公布： WO2002014311 20020221
- 主分类号： C07D417/14
- IPC分类号： C07D417/14
摘要：
Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
公开/授权文献
- EP1309589A2 UREA COMPOUNDS AND METHODS OF USES 公开/授权日：2003-05-14
信息查询
